In conclusion, TFE3 immunostaining and fusion gene ASPL-TFE3 expression may provide information for clinical molecular pathological diagnosis and improve the diagnostic rate of ASPS. The gene discussed is ASPSCR1; the disease is alveolar soft part sarcoma.